$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
How much does entrectinib cost? How much does an individual pay after medical insurance reimbursement?
2026-02-01 22:25:32
Check Details
What is acalatinib/acatinib?
2026-02-01 22:25:32
Check Details
First-line Tamibarotene combined with Venetoclax and azacitidine induces 100% CR rate in SELECT-AML-1 trial
2026-02-01 22:25:32
Check Details
MRD-guided ibrutinib/Venetoclax brings PFS benefit in CLL
2026-02-01 22:25:32
Check Details
What is the required concentration of venetoclax/venetoclax?
2026-02-01 22:25:32
Check Details
Can venetoclax/venetoclax be used long-term?
2026-02-01 22:25:32
Check Details
Is Venetoclax/Venetoclax better to be domestically produced or imported?
2026-02-01 22:25:32
Check Details
Is venetoclax/venetoclax a targeted drug or a chemotherapy drug?
2026-02-01 22:25:32
Check Details
What are the side effects of venetoclax/venetoclax and how long do they last?
2026-02-01 22:25:32
Check Details
Can I be reimbursed for Venetoclax/Venetoclax? What is the price after medical insurance?
2026-02-01 22:25:32
Check Details
Must-read for patients: Efficacy and side effects of venetoclax/venetoclax tablets
2026-02-01 22:25:32
Check Details
Where can I buy venetoclax/venetoclax tablets and how much can patients buy a box of them?
2026-02-01 22:25:32
Check Details
1
2
...
500
501
502
503
504
505
506
...
10237
10238
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
After Ibrutinib Resistance: CLL/SLL and MCL Next Steps, Progression vs Intolerance
2
Tucatinib HER2 TKI: With Trastuzumab + Capecitabine, Diarrhea and Hepatotoxicity Monitoring
3
Quizartinib for FLT3-ITD AML: Induction-Consolidation-Maintenance and QT Monitoring
4
Dostarlimab for dMMR/MSI-H Locally Advanced Rectal Cancer: FDA Accelerated Approval and AZUR-1
5
Ibrutinib for Mantle Cell Lymphoma: BTK Mechanism, Response Is Not Cure, Post-Resistance Options
6
Filgotinib JAK1 Inhibitor: RA and Ulcerative Colitis Dosing, Infection/Thrombosis Risks, Pregnancy Contraindication
7
Daprodustat for Dialysis CKD Anemia: HIF Mechanism, Thrombotic Black Box Warning, Blood Pressure and GI Monitoring
8
Pemigatinib for FGFR2-Rearranged Cholangiocarcinoma: Eligibility, Response Limits, Hyperphosphatemia and Ocular Monitoring
9
Cabozantinib with Aspirin: Additive Bleeding Risk, Do Not Stop Cardiac Aspirin Alone, Urgent Warning Signs
10
Bosentan Key Prescribing Points: Indication, Dosage, Risks, and Monitoring
11
Ambrisentan and IgA Nephropathy: Does It Reduce Proteinuria and Is It Safe?
12
Stiripentol for Dravet Syndrome With Clobazam: Weight-Based Dosing, Food Administration, Somnolence and Blood Count Monitoring